During the past decade, accumulating evidence from the research highlights the suggested
effects of bacterial communities of the human gut microbiota and their metabolites on health …

Mounting evidence suggests safety and efficacy of psychedelic compounds as potential
novel therapeutics in psychiatry. Ketamine has been approved by the Food and Drug …

Emerging evidence suggests that astrocyte loss is one of the most important pathological
features in the hippocampus of patients with major depressive disorder (MDD) and …

Sleep deprivation (SD) is increasingly common in modern society, which can lead to the
dysregulation of inflammatory responses and cognitive impairment, but the mechanisms …

Major depressive disorder (MDD) is a psychiatric condition that affects a large number of
people in the world, and the treatment existents do not work for all individuals affected. Thus …

The α7 subtype of the nicotinic acetylcholine receptor (α7 nAChR: coded by Chrna7)
regulates the cholinergic ascending anti-inflammatory pathway involved in depression. We …

Nod-like receptor protein 3 (NLRP3)-associated neuroinflammation mediated by activated
microglia is involved in the pathogenesis of depression. The role of the pore-forming protein …

Schizophrenia is a heterogeneous neurodevelopmental disorder involving the convergence
of a complex and dynamic bidirectional interaction of genetic expression and the …

Chronic stress is well-known to cause physiological distress that leads to body balance
perturbations by altering signaling pathways in the neuroendocrine and sympathetic …

Anxiety and eating disorders produce a physiological imbalance that triggers alterations in
the abundance and composition of gut microbiota. Moreover, the gut–brain axis can be …